This invention relates to novel compounds that are deuterated derivatives of fingolimod and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering a lysophospholipid edgl (SlPl) receptor agonist, such as fingolimod.
申请公布号
WO2009061374(A2)
申请公布日期
2009.05.14
申请号
WO2008US12390
申请日期
2008.10.31
申请人
CONCERT PHARMACEUTICALS, INC.;LIU, JULIE, F.;PERSICHETTI, ROSE, A.